Literature DB >> 21993430

Systematic review and empirical comparison of contemporaneous EQ-5D and SF-6D group mean scores.

David G T Whitehurst1,2, Stirling Bryan1, Martyn Lewis2.   

Abstract

BACKGROUND: Group mean estimates and their underlying distributions are the focus of assessment for cost and outcome variables in economic evaluation. Research focusing on the comparability of alternative preference-based measures of health-related quality of life has typically focused on analysis of individual-level data within specific clinical specialties or community-based samples.
PURPOSE: To explore the relationship between group mean scores for the EQ-5D and SF-6D across the utility scoring range.
METHODS: Studies were identified via a systematic search of 13 online electronic databases, a review of reference lists of included papers, and hand searches of key journals. Studies were included if they reported contemporaneous mean EQ-5D and SF-6D health state scores. All (sub)group comparisons of group mean EQ-5D and SF-6D scores identifiable from text, tables, or figures were extracted from identified studies. A total of 921 group mean comparisons were extracted from 56 studies. The nature of the relationship between the paired scores was examined using ranked scatter graphs and analysis of agreement.
RESULTS: Systematic differences in group mean estimates were observed at both ends of the utility scale. At the lower (upper) end of the scale, the SF-6D (EQ-5D) provides higher mean utility estimates.
CONCLUSIONS: These findings show that group mean EQ-5D and SF-6D scores are not directly comparable. This raises serious concerns about the cross-study comparability of economic evaluations that differ in the choice of preference-based measures, although the review focuses on 2 of the available instruments only. Further work is needed to address the practical implications of noninterchangeable utility estimates for cost-per-QALY estimates and decision making.

Mesh:

Year:  2011        PMID: 21993430     DOI: 10.1177/0272989X11421529

Source DB:  PubMed          Journal:  Med Decis Making        ISSN: 0272-989X            Impact factor:   2.583


  25 in total

Review 1.  An educational review of the statistical issues in analysing utility data for cost-utility analysis.

Authors:  Rachael Maree Hunter; Gianluca Baio; Thomas Butt; Stephen Morris; Jeff Round; Nick Freemantle
Journal:  Pharmacoeconomics       Date:  2015-04       Impact factor: 4.981

2.  Framing of mobility items: a source of poor agreement between preference-based health-related quality of life instruments in a population of individuals receiving assisted ventilation.

Authors:  Liam M Hannan; David G T Whitehurst; Stirling Bryan; Jeremy D Road; Christine F McDonald; David J Berlowitz; Mark E Howard
Journal:  Qual Life Res       Date:  2017-03-02       Impact factor: 4.147

Review 3.  Estimates of utility weights in hemophilia: implications for cost-utility analysis of clotting factor prophylaxis.

Authors:  Scott D Grosse; Shraddha S Chaugule; Joel W Hay
Journal:  Expert Rev Pharmacoecon Outcomes Res       Date:  2015-01-14       Impact factor: 2.217

4.  Health state descriptions, valuations and individuals' capacity to walk: a comparative evaluation of preference-based instruments in the context of spinal cord injury.

Authors:  David G T Whitehurst; Nicole Mittmann; Vanessa K Noonan; Marcel F Dvorak; Stirling Bryan
Journal:  Qual Life Res       Date:  2016-04-20       Impact factor: 4.147

5.  Validation and comparison of the psychometric properties of the EQ-5D-3L and EQ-5D-5L instruments in Greece.

Authors:  John N Yfantopoulos; Athanasios E Chantzaras
Journal:  Eur J Health Econ       Date:  2016-06-04

6.  Comparative performance of the EQ-5D-5L and SF-6D index scores in adults with type 2 diabetes.

Authors:  Fatima Al Sayah; Weiyu Qiu; Feng Xie; Jeffrey A Johnson
Journal:  Qual Life Res       Date:  2017-03-31       Impact factor: 4.147

7.  Cost effectiveness of telecare management for pain and depression in patients with cancer: results from a randomized trial.

Authors:  Sung J Choi Yoo; John A Nyman; Andrea L Cheville; Kurt Kroenke
Journal:  Gen Hosp Psychiatry       Date:  2014-07-19       Impact factor: 3.238

Review 8.  The Use of Health State Utility Values in Decision Models.

Authors:  Roberta Ara; John Brazier; Ismail Azzabi Zouraq
Journal:  Pharmacoeconomics       Date:  2017-12       Impact factor: 4.981

9.  Comparison of the EQ-5D-3L and the SF-6D (SF-12) contemporaneous utility scores in patients with cardiovascular disease.

Authors:  Sanjeewa Kularatna; Joshua Byrnes; Yih Kai Chan; Chantal F Ski; Melinda Carrington; David Thompson; Simon Stewart; Paul A Scuffham
Journal:  Qual Life Res       Date:  2017-08-01       Impact factor: 4.147

10.  The authors' reply to Koeser and McCrone: "on the use and interpretation of quantile regression in quality-of-life research".

Authors:  Michela Tinelli; Anthony Scott; Janelle Seymour; Mandy Ryan; Christine Bond; Paul McNamee
Journal:  Pharmacoeconomics       Date:  2014-02       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.